ATE329031T1 - Therapeutische zusammensetzungen zur behandlung von lawsonia intracellularis infektionen - Google Patents

Therapeutische zusammensetzungen zur behandlung von lawsonia intracellularis infektionen

Info

Publication number
ATE329031T1
ATE329031T1 AT96938863T AT96938863T ATE329031T1 AT E329031 T1 ATE329031 T1 AT E329031T1 AT 96938863 T AT96938863 T AT 96938863T AT 96938863 T AT96938863 T AT 96938863T AT E329031 T1 ATE329031 T1 AT E329031T1
Authority
AT
Austria
Prior art keywords
treatment
lawsonia intracellularis
therapeutic compositions
intracellularis infections
prophylaxis
Prior art date
Application number
AT96938863T
Other languages
English (en)
Inventor
Michael Panaccio
Detlef Hasse
Original Assignee
Agriculture Victoria Serv Pty
Australian Pork Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPN6910A external-priority patent/AUPN691095A0/en
Priority claimed from AUPN6911A external-priority patent/AUPN691195A0/en
Application filed by Agriculture Victoria Serv Pty, Australian Pork Ltd filed Critical Agriculture Victoria Serv Pty
Application granted granted Critical
Publication of ATE329031T1 publication Critical patent/ATE329031T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/825—Bacterial vaccine for porcine species, e.g. swine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96938863T 1995-11-30 1996-11-29 Therapeutische zusammensetzungen zur behandlung von lawsonia intracellularis infektionen ATE329031T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPN6910A AUPN691095A0 (en) 1995-11-30 1995-11-30 Therapeutic and diagnostic compositions - A
AUPN6911A AUPN691195A0 (en) 1995-11-30 1995-11-30 Therapeutic and diagnostic compositions - B

Publications (1)

Publication Number Publication Date
ATE329031T1 true ATE329031T1 (de) 2006-06-15

Family

ID=25645072

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96938863T ATE329031T1 (de) 1995-11-30 1996-11-29 Therapeutische zusammensetzungen zur behandlung von lawsonia intracellularis infektionen

Country Status (11)

Country Link
US (1) US7022328B1 (de)
EP (1) EP0871735B1 (de)
JP (1) JP2000502054A (de)
CN (1) CN1145697C (de)
AT (1) ATE329031T1 (de)
AU (1) AU718333B2 (de)
BR (1) BR9611623A (de)
CA (1) CA2236574A1 (de)
DE (1) DE69636228D1 (de)
NZ (1) NZ322398A (de)
WO (1) WO1997020050A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2345061A (en) * 1998-12-21 2000-06-28 Secr Defence Protein and nucleic acid sequences of groES and groEL from B.pseudomallei and their use as a vaccine
US7052697B1 (en) * 1999-05-13 2006-05-30 Agriculture Victoria Services Pty Ltd Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses
NZ515331A (en) * 1999-05-13 2003-07-25 Pfizer Prod Inc Lawsonia derived gene and related FlgE polypeptides, peptides and proteins and their uses
AU767390B2 (en) * 1999-05-13 2003-11-06 Agriculture Victoria Services Pty Ltd (lawsonia) derived gene and related OmpH polypeptides, peptides and proteins and their uses
JP2003501013A (ja) * 1999-05-13 2003-01-14 ファイザー プロダクツ インコーポレーティッド ローソニア由来の遺伝子及び関連ＳｏｄＣポリペプチド、ぺプチド及びタンパク質並びにそれらの使用
US7029683B1 (en) 1999-05-13 2006-04-18 Pfizer Products, Inc. Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses
EP1177213A4 (de) * 1999-05-13 2002-08-28 Pfizer Prod Inc Von lawsonia stammendes gen und assoziierte hämolysin-polypeptide, peptide und proteine und ihre verwendungen
EP1094070A3 (de) * 1999-10-22 2002-01-09 Pfizer Products Inc. Lawsonia intracellularis Proteine sowie Methoden und Materialien die diese verwenden
US6605696B1 (en) 1999-10-22 2003-08-12 Pfizer, Inc. Lawsonia intracellularis proteins, and related methods and materials
GB0021757D0 (en) * 2000-09-04 2000-10-18 Colaco Camilo Vaccine against microbial pathogens
EP1324768A2 (de) * 2000-09-29 2003-07-09 The Arizona Board of Regents on Behalf of the University of Arizona Impfstoffe gegen proliferative ileitis
CA2399276A1 (en) * 2000-11-10 2002-05-16 Agriculture Victoria Services Pty, Ltd. Novel therapeutic compositions for treating infection by lawsonia spp
DE60120621T2 (de) 2000-12-20 2006-12-14 Intervet International B. V. Lawsonia intracellularis Impfstoff
MY146476A (en) 2004-06-24 2012-08-15 Boehringer Ingelheim Vetmed Method of diagnosing lawsonia intracellularis
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
JP2009509496A (ja) * 2005-04-28 2009-03-12 ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド ローソニアイントラセルラリスの免疫学的タンパク
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US8470336B2 (en) * 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
US20080241190A1 (en) * 2006-11-13 2008-10-02 Boehringer Ingelheim Vetmedica, Inc. Vaccination of horses against lawsonia intracellularis
EP2859900A1 (de) 2006-12-11 2015-04-15 Boehringer Ingelheim Vetmedica, Inc. Wirksames Verfahren zur Behandlung von Infektionen mit dem porcinen Circovirus und Lawsonia intracellularis
EP2200643B1 (de) 2007-09-17 2013-09-04 Boehringer Ingelheim Vetmedica, Inc. Ein lawsonia intracellularis lebendimpfstoff verabreicht in kombination mit einem antibiotikum zur behandlung von lawsonia intracellularis infektionen in schweine
TWI551295B (zh) 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
RU2523561C2 (ru) * 2008-04-18 2014-07-20 Интервет Интернэшнл Б.В. Вакцина для защиты от lawsonia intracellularis
TWI449533B (zh) * 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
ES2534556T3 (es) * 2008-07-22 2015-04-24 Intervet International Bv Bacteria Lawsonia intracellularis de un nuevo serotipo, vacuna basada en esa bacteria, anticuerpos adecuados para diagnosticar el nuevo serotipo de Lawsonia intracellularis e hibridomas para producir dichos anticuerpos
US8142760B2 (en) * 2008-09-05 2012-03-27 Nathan Len Winkelman Vaccination for Lawsonia intracellularis
JP6484241B2 (ja) * 2013-12-03 2019-03-13 インターベット インターナショナル ベー． フェー． ＰＲＲＳおよびローソニア・イントラセルラリス（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）に対するブタワクチン
EP3076995B1 (de) 2013-12-03 2020-03-11 Intervet International B.V. Impfstoff gegen lawsonia intracellularis und porcine circovirus typ 2
CA2931137C (en) 2013-12-03 2023-03-14 Intervet International B.V. Vaccine against porcine circo virus type 2
EP3253409B1 (de) * 2015-02-04 2020-05-06 Intervet International B.V. Impfstoff zur verwendung gegen subklinische lawsonia-infektion bei einem schwein
EP3253410B1 (de) * 2015-02-04 2020-05-06 Intervet International B.V. Impfstoff zur verwendung gegen subklinische lawsonia-infektion bei einem schwein
JP7139437B2 (ja) 2018-02-28 2022-09-20 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー 動物内のスカトール及び／又はインドールの低減方法
WO2023073640A1 (en) 2021-11-01 2023-05-04 Boehringer Ingelheim Vetmedica Gmbh Immunogenic gel compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610059A (en) 1992-11-09 1997-03-11 University Of Arizona Etiological agent for porcine enteritis
WO1995014093A1 (en) 1993-05-19 1995-05-26 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
US5714375A (en) * 1995-06-05 1998-02-03 Nobl Laboratories, Inc. Ileal symbiont intracellularis propagation in suspended host cells
US5885823A (en) 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
US6379677B1 (en) * 2000-02-25 2002-04-30 The United States Of America As Represented By The Secretary Of The Department Of Agriculture Streptococcus iniae vaccine

Also Published As

Publication number Publication date
AU718333B2 (en) 2000-04-13
EP0871735B1 (de) 2006-06-07
JP2000502054A (ja) 2000-02-22
WO1997020050A1 (en) 1997-06-05
US7022328B1 (en) 2006-04-04
CN1203630A (zh) 1998-12-30
DE69636228D1 (de) 2006-07-20
EP0871735A1 (de) 1998-10-21
CA2236574A1 (en) 1997-06-05
CN1145697C (zh) 2004-04-14
AU7614196A (en) 1997-06-19
EP0871735A4 (de) 2001-12-05
BR9611623A (pt) 1999-12-28
NZ322398A (en) 2000-02-28

Similar Documents

Publication Publication Date Title
DE69636228D1 (de) Therapeutische Zusammensetzungen zur Behandlung von Lawsonia intracellularis Infektionen
ATE154935T1 (de) Zweite amine als antidiabetische mittel und für die behandlung von fettleibigkeit
ATE218880T1 (de) Verfahren zur behandlung von gram-negativen bakterien infektion durch verabreichung von bakterientötendem/durchlässigkeiterhöhendem (bpi) proteinprodukt und antibiotikum
ATE310391T1 (de) Verfahren und zusammensetzung zur vorbeugung und behandlung von mit clostridium difficile assoziierten erkrankungen
DE60325945D1 (de) Zusammensetzungen und verfahren für die behandlung von mikroorganismen-infektionen
YU46097A (sh) Nova klasa estara i njihove farmaceutske smeše
DE69934010D1 (de) Zusammensetzungen zur behandlung von chlamydiale assozierten krankheiten
FR2599257B1 (fr) Agent neutralisant les odeurs desagreables des excretions et excrements des animaux.
DE60213404D1 (de) Verwendung von sulodexid zur behandlung von reizdarm
HUP0100566A2 (hu) Új eritromicinszármazékok
BR0015698A (pt) Composições e métodos para tratamento de doenças alérgicas
Kampelmacher et al. Listeriosis in humans and animals in the Netherlands (1958–1977)
DE69628336D1 (de) Behandlung und diagnose helicobacter pylori infektionen
RU94020410A (ru) Способ лечения или профилактики рвоты у млекопитающих и человека с использованием некоторых хинуклидиновых, пиперидиновых, азанорборнановых, этилендиаминовых производных и родственных им соединений
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
ATE258057T1 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
ATE289821T1 (de) Verfahren zur behandlung einer diarrhöischen krankheit und zur eliminierung besonderer bakterieller populationen im dickdarm
ATE408618T1 (de) Synthetische peptidkonstrukte zur erkennung und behandlung von parodontose hervorgerufen durch porphyromonas gingivalis
DE60035693D1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
SE8903625D0 (sv) Antibacterial composition
DE50014268D1 (de) Zusammensetzung, enthaltend bakterielle antigene, zum vorbeugen und behandeln von allergischen erkrankungen
EA200001029A1 (ru) Производные гигромицина
EP0966196A4 (de) Zusammensetzung zur organ-kryokonservierung und behandlung von viralen und bakteriellen infektionen
DE60114778D1 (de) Behandlung von infektionen in tieren
DE69829995D1 (de) Multivalente rekombinante antikörper zur behandlung von hrv infektionen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties